abeLacimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for abeLacimab, covering 2025-07-30 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE [Phase 3]